-
ANEB Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Anebulo Pharmaceuticals (ANEB)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.40 mm | 1.40 mm | 1.40 mm | 1.40 mm | 1.40 mm | |
Cash burn (monthly) | 383.57 k | 804.04 k | 643.02 k | 563.33 k | 519.21 k | |
Cash used (since last report) | 1.07 mm | 2.25 mm | 1.80 mm | 1.58 mm | 1.45 mm | |
Cash remaining | 329.94 k | -847.66 k | -396.69 k | -173.50 k | -49.93 k | |
Runway (months of cash) | 0.9 | -1.1 | -0.6 | -0.3 | -0.1 |
13F holders | Current |
---|---|
Total holders | 8 |
Opened positions | 3 |
Closed positions | 9 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 19.32 bn |
Total shares | 11.73 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
22NW | 5.37 mm | $14.65 bn |
Aron R. English | 4.65 mm | $0.00 |
LVW Advisors | 642.04 k | $1.75 bn |
Nantahala Capital Management | 511.07 k | $1.40 bn |
MS Morgan Stanley | 399.22 k | $1.09 bn |
Ikarian Capital | 157.86 k | $430.96 mm |
BAC Bank of America | 65.00 | $177.00 k |
RY Royal Bank of Canada | 51.00 | $0.00 |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Dec 24 | Richard Anthony Cunningham, | Stock Option Common Stock | Grant | Acquire A | No | No | 1.56 | 254,433 | 396.92 k | 254,433 |
13 Jun 24 | Nathaniel Calloway | Stock Option Common Stock | Grant | Acquire A | No | No | 2.1 | 1,655 | 3.48 k | 1,655 |
13 Jun 24 | Nathaniel Calloway | Stock Option Common Stock | Grant | Acquire A | No | No | 2.1 | 41,667 | 87.50 k | 41,667 |
13 Jun 24 | Aron R. English | Stock Option Common Stock | Grant | Acquire A | No | No | 2.1 | 1,324 | 2.78 k | 1,324 |
13 Jun 24 | Aron R. English | Stock Option Common Stock | Grant | Acquire A | No | No | 2.1 | 41,667 | 87.50 k | 41,667 |
13 Jun 24 | Areta Kupchyk | Stock Option Common Stock | Grant | Acquire A | No | No | 2.1 | 1,324 | 2.78 k | 1,324 |
13 Jun 24 | Areta Kupchyk | Stock Option Common Stock | Grant | Acquire A | No | No | 2.1 | 41,667 | 87.50 k | 41,667 |
13 Jun 24 | Aryeh Jason | Stock Option Common Stock | Grant | Acquire A | No | No | 2.1 | 2,482 | 5.21 k | 2,482 |
13 Jun 24 | Aryeh Jason | Stock Option Common Stock | Grant | Acquire A | No | No | 2.1 | 41,667 | 87.50 k | 41,667 |